Literature DB >> 8025779

Recovery of function in survivors of the acute respiratory distress syndrome.

L G McHugh1, J A Milberg, M E Whitcomb, R B Schoene, R J Maunder, L D Hudson.   

Abstract

We performed a prospective cohort analysis to determine the rate and extent of improvement in pulmonary function abnormalities and self-perceived health for 1 yr after surviving an episode of the acute respiratory distress syndrome (ARDS). We also examined the effect of ARDS severity and etiology, age, and sex on functional recovery. Patients were recruited from the intensive care units of one hospital and followed at regular time intervals from extubation to 1 yr. Fifty-two of 82 eligible adult survivors (63%) consented to participate; 37 of 82 (45%) had at least two examinations, and 20 (24%) had complete follow-up. Risk factors for ARDS included sepsis (n = 12), trauma (n = 15), and other (n = 10). Pulmonary function and self-perceived health scores improved considerably in the first 3 mo after extubation, with only slight additional improvement at 6 mo. No further changes were evident at 1 yr. Patients with more severe ARDS had significantly lower pulmonary function tests than did other survivors throughout follow-up. These observations should be useful for clinical follow-up of ARDS survivors and provide specific information concerning the expected rate of functional recovery in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 8025779     DOI: 10.1164/ajrccm.150.1.8025779

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  46 in total

1.  Quality of life following critical care: moving beyond survival.

Authors:  D K Heyland; D J Kutsogiannis
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 2.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

3.  Experimental Lung Injury Promotes Changes in Oxidative/Nitrative Status and Inflammatory Markers in Cerebral Cortex of Rats.

Authors:  Maira J da Cunha; Aline A da Cunha; Samanta O Loureiro; Fernanda R Machado; Felipe Schmitz; Janaína Kolling; Eduardo P Marques; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

4.  Health status after critical illness: beyond descriptive studies.

Authors:  Gordon D Rubenfeld; J Randall Curtis
Journal:  Intensive Care Med       Date:  2003-10       Impact factor: 17.440

5.  Surviving intensive care: a report from the 2002 Brussels Roundtable.

Authors:  Derek C Angus; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

6.  High tidal volume decreases adult respiratory distress syndrome, atelectasis, and ventilator days compared with low tidal volume in pediatric burned patients with inhalation injury.

Authors:  Linda E Sousse; David N Herndon; Clark R Andersen; Arham Ali; Nicole C Benjamin; Thomas Granchi; Oscar E Suman; Ronald P Mlcak
Journal:  J Am Coll Surg       Date:  2015-01-05       Impact factor: 6.113

7.  Expanding our horizons beyond the intensive care unit: does mechanism of lung injury influence the quality of life in ARDS survivors?

Authors:  Salvatore Maurizio Maggiore; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

8.  Pilot Feasibility Study of Therapeutic Hypothermia for Moderate to Severe Acute Respiratory Distress Syndrome.

Authors:  Donald F Slack; Douglas S Corwin; Nirav G Shah; Carl B Shanholtz; Avelino C Verceles; Giora Netzer; Kevin M Jones; Clayton H Brown; Michael L Terrin; Jeffrey D Hasday
Journal:  Crit Care Med       Date:  2017-07       Impact factor: 7.598

9.  Mobile, awake and critically ill.

Authors:  Margaret S Herridge
Journal:  CMAJ       Date:  2008-03-11       Impact factor: 8.262

10.  Clinical Aspects of Acute Lung Insufficiency (ALI/TRALI).

Authors:  Matthias Hecker; Hans-Dieter Walmrath; Werner Seeger; Konstantin Mayer
Journal:  Transfus Med Hemother       Date:  2008-03-10       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.